Further large-scale, prospective, and methodologically rigorous studies are required to clarify its prognostic value, reduce uncertainty, and determine whether incorporating Lp(a) into existing risk models could improve clinical decision-making for stroke prevention in this population. This evidence concerns the gene LPA and Stroke.